Building strong and lasting partnership is essential to success of our research and business. We pursue innovation through both internal R&D and external collaboration. Partnerships and collaborations are critical to evolving our portfolio and driving our long-term sustainability.

Out-licensing: we seek partners with global R&D and commercial expertise to help realize the full potential of our innovative assets  on global or regional level

In-licensing: we are constantly seeking and evaluating both clinical stage assets that may complement our in-house pipeline and first-in-class compounds with breakthrough potential.